Medical Expertise

- Limb salvage, endovascular and open procedures for Peripheral Artery Disease (PAD), diabetic
foot ulcers.
- Open and endovascular repair of Aortic Aneurysms and Dissections.
- Stroke Prevention, TCAR, carotid endarterectomy and carotid stenting.
- Thoracic Aortic Aneurysm repair, open and endovascular.
- Catheter based procedures for Deep Vein Thrombosis (DVT) and other venous diseases
- Hemodialysis access and maintenance.
- Office based procedures for varicose veins and spider veins

Hospital Affiliation

University Hospital, Newark

INSURANCE PARTICIPATION

Insurance Participation: with Provider Number (where applicable)
The information below is subject to change and should not be relied upon until after it is verified with the insurance company. In addition, psychiatric providers should be contacted directly for information on their participation with managed care and insurance companies.

Aetna, Inc.

AmeriGroup

AmeriHealth of NJ

America's Choice Provider Network (ACPN)

Amerivantage Dual Coordination

Clover Health Plans

Devon Health Services/ULLICO

Horizon BCBS Managed Care

Horizon NJ Health

Horizon NJ Total Care(HNJH)

Horizon PPO Network

Medicaid

Medicare

MultiPlan

Prime Health Services, Inc.

Qual Care HMO

Qual Care PPO

Three Rivers Provider Network

UHC Comm/Oxford

United Healthcare Community Plan (formerly AmeriChoice of NJ, Inc.)

WellCare Health Plans

Languages

Hindi
Punjabi
Urdu

Overview

Dr. Saqib Zia is an Associate Professor in the Department of Surgery, Division of
Vascular Surgery, Attending at University Hospital (UH) and also the Program Director
for Vascular Surgery Fellowship Program.

After finishing his medical education at King Edward Medical University, Dr. Zia
completed Basic Surgical Training at Whipps Cross University Hospital in London, UK,
during which he completed the Member of Royal College of Surgeons of England
examinations. He completed his general surgery internship at University of Virginia,
followed by residency at University of Wisconsin-Madison. Dr. Zia completed a
vascular and endovascular surgery fellowship at Staten Island University Hospital. Prior to
joining Rutgers NJMS, he developed a very busy practice as an attending in vascular
surgeon and Assistant Professor of Surgery at Zucker School of Medicine at Hofstra
Northwell Staten Island University Hospital. Dr. Zia is Board Certified by the
American Board of Surgery in General as well as Vascular Surgery. He is a Fellow of the
American College of Surgeons and is a Registered Physician in Vascular Interpretation (RPVI).
During his tenure at NJMS as the vascular surgery program director, he spearheaded the initial
ACGME accreditation for a new vascular surgery integrated residency program to complement the
well established vascular fellowship.

Education

MD, 2001, King Edward Medical University
BS, 1995, Forman Christian College

Licensure & Certification

Medical Licensure
New Jersey

Certification
American Board of Surgery - Vascular Surgery

Languages

Hindi
Punjabi
Urdu

Relevant Publications

Patel P, Yu Y, Zia S, Padberg F, Curi M, Huang J. Systemic Thrombolysis as Initial Treatment of COVID-19 Associated Acute Aortoiliac and Lower Extremity Arterial Thrombosis. Ann Vasc Surg. 2021 Jan;70:297-301. doi: 10.1016/j.avsg.2020.08.083. Epub 2020 Aug 28. PMID: 32861850; PMCID: PMC7453212.

Managing Central Venous Access during a Healthcare Crisis- J Vasc Surg. 2020 Oct;72(4):1184- 1195.e3. doi: 10.1016/j.jvs.2020.06.112. Epub 2020 Jul 15 PMID: 32682063

Singh K, Juneja A, Bajaj T, Voto C, Schor J, Zia S, Deitch J. Single Tertiary Care Center Outcomes After Lower Extremity Cadaveric Vein Bypass for Limb Salvage. Vasc Endovascular Surg. 2021 Feb;55(2):204. doi: 10.1177/1538574420966452. Epub 2020 Oct 29. PMID: 33118465

Juneja A, Zia S, Abeysekara A, Shams S, Singh K, Schor J, Deitch J. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers have no effect on the outcomes of endovascular revascularization in tibial arterial occlusive disease. Vascul Pharmacol. 2020 Aug;131:106764. doi: 10.1016/j.vph.2020.106764. Epub 2020 Jul 3. PMID: 32629143.

Guerges M, Zia S. Endovascular Repair of Carotid Artery Pseudoaneurysm using Transcarotid Artery Revascularization Flow Reversal Technique. Ann Vasc Surg. 2020 Jul;66:668.e11-668.e14. doi: 10.1016/j.avsg.2019.12.024. Epub 2020 Jan 9. PMID: 31926273

Zia S, Juneja A, Shams S, Faheem B, Shariff M, Singh K, Schor J, Deitch J. Contemporary Outcomes of Infrapopliteal Atherectomy versus Balloon Angioplasty Alone for Critical Limb Ischemia. Zia S, Juneja A, Shams S, Faheem B, Shariff MA, Singh K, Schor J, Deitch J. J Vasc Surg. 2020 Jun;71(6):2056-2064. doi: 10.1016/j.jvs.2019.08.254. Epub 2019 Nov 11. PMID: 31727459

Juneja A, Zia S, Ayad MH, Singh K, Dietch J, Schor J. Safety and Feasibility of Performing Fenestrated Endovascular Abdominal Aneurysm Repair Using a Portable C-arm Without Fusion Technology: A Single-Center Experience. Cureus. 2020 Apr 20;12(4):e7739. doi: 10.7759/cureus.7739. PMID: 32455059

Zia S, Simons J, Woo K, Rathbun J, Ryan P. Merit-Based incentive payment system year 3 quality reporting options. J Vasc Surg. 2019 Jul;70(1):327. doi: 10.1016/j.jvs.2019.04.463. PMID: 31230650

Tyson AC, Parikh S, Singh K, Zia S, Deitch JS, Schor JA. Routine Postoperative Cardiac Testing is Unnecessary after Carotid Endarterectomy. Ann Vasc Surg. 2019 Aug;59:12-15. doi: 10.1016/j.avsg.2018.11.028 PMID: 30769059

Zia S, Singh K, Juneja A, Schor J, Deitch J. Safety and Feasibility of Trans-radial Access for Non Coronary and Peripheral Vascular Interventions. Ann Vasc Surg. 2018 Nov;53:255-261. doi: 10.1016/j.avsg.2018.04.003 PMID: 29885431

Course List

SURG9266K

A.I. Vascular Surgery

A. Principal Investigator
1. ClotTriever Outcomes (CLOUT) Registry. Rutgers New Jersey Medical School. April 2021.
https://clinicaltrials.gov/ct2/show/NCT03575364
2. GORE Educational Grant for Vascular Surgery Fellowship. Rutgers New Jersey Medical School.
April 2021. $10,000
3. 19-0334-SIUHN ClotTriever Outcomes (CLOUT) Registry. Staten Island University Hospital
North 2019. $61,950
4. 18-0204-SIUHN Bard?? LifeStent?? Popliteal Artery Stent Project. Staten Island University
Hospital North 2018. $1,700

B. Co-Investigator
1. Humacyte CLN-PRO-V007: Phase 3, prospective, multicenter, open-label, randomized, two-arm,
comparative study. Subjects with end-stage renal disease (ESRD) randomized to receive either a
human acellular vessel (HAV) or arteriovenous fistula (AVF). Rutgers- New Jersey Medical School.
Enrolling since August 2017.
2. CLN-PRO-V005. A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacyte???s
Human Acellular Vessel for Use as a Vascular Bypass or Interposition Vessel in Patients with Limb-
threatening Peripheral Arterial Trauma. Rutgers- New Jersey Medical School. Enrolling since January
2018.
3. 18-0091-SIUHN Chronic Venous Thrombosis: Relief with Adjunctive Catheter- Directed Therapy:
The C-Tract Trial. (The C-TRACT Trial) (C-TRACT), ClinicalTrial.gov -NCT03250247 2018. $10,500.
4. 15-093-SIUHN Trial to Compare Best Endovascular versus Best Surgical Therapy in Patients
with Critical Limb Ischemia (BEST-CLI) 2015. $12,000
5. 16-883-SIUHN. RANGER II SFA: A 3:1 Randomized Trial Comparing the Boston Scientific
RANGER??? Paclitaxel Coated Balloon vs Standard Balloon Angioplasty for the Treatment of
Superficial Femoral Arteries (SFA) and Proximal Popliteal Arteries (PPA). 2016. $10,601
6. 17-0625-SIUHN A Prospective, Multi-Center, Single-Arm, Real-World Study Assessing the
Clinical Use of the Bard?? UltraScore??? Focused Force PTA Balloon. 2017. $27,274
7. HS15-0561-SIUHN Assessment of the GORE?? EXCLUDER?? Conformable AAA
Endoprosthesis(CEXC Device) in the Treatment of Abdominal Aortic Aneurysms. 2015. $12,112